Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?

Cardiovascular diseasesdrug prescriptionsgeneral practiceold agesecondary preventionthe Netherlandsvulnerability